drgmoney

Access Pharma Looking for Smooth U.S. MuGard Launch in 2010

Do you know if the post marketing Data on Mugard in Europe will be published in a peer review journal??

FDA Calendar Updates: Orexo, Novo Nordisk, King, Isis, Facet

Mike, I know you always post a disclosure in your articles as to whether you personally own a stock. have you ever printed a list of stocks you own and if so where can I access (no pun intended - but thanks for the tip) it?

Access Pharma: Deep Pipeline, Shallow Valuation

Mike, have you heard anything in regards to Milestone beginning marketing of mugard in the US? It has been approved for more than a year

Seven New Extreme Biotech Trades

JAV also has a intranasal ketamine product called Ereska with phase III data due in next few weeks and plan to file an NDA for this as well if data are good. so possibly 2 NDA's in next 6 months. Dyloject will complete with Toradol the only FDA approved intravenous NSAID. disclosure: own JAV

FDA Calendar Updates: Transdel, Javelin, Jazz, Par Pharma

Also have Phase III safety data due this summer to support their NDA for dyloject which should be good as previous Phase III trials had superior safety data to toradol

FDA Calendar Updates: Transdel, Javelin, Jazz, Par Pharma

Don't forget JAV is due to release phase III results for their intranasal ketamine product ERESKA in the next few weeks.